Literature DB >> 32115655

Circulating let-7g-5p and miR-191-5p Are Independent Predictors of Chronic Kidney Disease in Hypertensive Patients.

Olga Berillo1, Ku-Geng Huo1, Júlio C Fraulob-Aquino1, Chantal Richer2, Marie Briet1,3, Pierre Boutouyrie4, Mark L Lipman1,5, Daniel Sinnett2,6, Pierre Paradis1, Ernesto L Schiffrin1,5.   

Abstract

BACKGROUND: Hypertension (HTN) is associated with target organ damage such as cardiac, vascular, and kidney injury. Several studies have investigated circulating microRNAs (miRNAs) as biomarkers of cardiovascular disease, but few have examined them as biomarker of target organ damage in HTN. We aimed to identify circulating miRNAs that could serve as biomarkers of HTN-induced target organ damage using an unbiased approach. METHODS AND
RESULTS: Fifteen normotensive subjects, 16 patients with HTN, 15 with HTN associated with other features of the metabolic syndrome (MetS), and 16 with HTN or chronic kidney disease (CKD) were studied. Circulating RNA extracted from platelet-poor plasma was used for small RNA sequencing. Differentially expressed (DE) genes were identified with a threshold of false discovery rate <0.1. DE miRNAs were identified uniquely associated with HTN, MetS, or CKD. However, only 2 downregulated DE miRNAs (let-7g-5p and miR-191-5p) could be validated by reverse transcription-quantitative PCR. Let-7g-5p was associated with large vessel stiffening, miR-191-5p with MetS, and both miRNAs with estimated glomerular filtration rate (eGFR) and neutrophil and lymphocyte fraction or number and neutrophil-to-lymphocyte ratio. Using the whole population, stepwise multiple linear regression generated a model showing that let-7g-5p, miR-191-5p, and urinary albumin/creatinine ratio predicted eGFR with an adjusted R2 of 0.46 (P = 8.5e-7).
CONCLUSIONS: We identified decreased circulating let-7g-5p and miR-191-5p as independent biomarkers of CKD among patients with HTN, which could have pathophysiological and therapeutic implications. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  biomarker; blood pressure; hypertension; microRNA; target organ damage

Mesh:

Substances:

Year:  2020        PMID: 32115655      PMCID: PMC7241936          DOI: 10.1093/ajh/hpaa031

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  39 in total

1.  Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease.

Authors:  Marie Briet; Gérard Maruani; Cédric Collin; Erwan Bozec; Cédric Gauci; Pierre Boutouyrie; Pascal Houillier; Stéphane Laurent; Marc Froissart
Journal:  Nephrol Dial Transplant       Date:  2009-08-04       Impact factor: 5.992

2.  Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.

Authors:  Abdimajid Osman; Knut Fälker
Journal:  Platelets       Date:  2011-03-25       Impact factor: 3.862

3.  miR-191 is involved in renal dysfunction in arsenic-exposed populations by regulating inflammatory response caused by arsenic from burning arsenic-contaminated coal.

Authors:  Y Xu; Z Zou; Y Liu; Q Wang; B Sun; Q Zeng; Q Liu; A Zhang
Journal:  Hum Exp Toxicol       Date:  2019-09-05       Impact factor: 2.903

4.  Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.

Authors:  Masayuki Kanki; Akira Moriguchi; Daisuke Sasaki; Hikaru Mitori; Atsushi Yamada; Akira Unami; Yoichi Miyamae
Journal:  Toxicology       Date:  2014-05-24       Impact factor: 4.221

Review 5.  Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update.

Authors:  Maxwell E Afari; Tariq Bhat
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-03-04

6.  Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension.

Authors:  J B Park; E L Schiffrin
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

7.  Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease.

Authors:  M Briet; E Bozec; S Laurent; C Fassot; G M London; C Jacquot; M Froissart; P Houillier; P Boutouyrie
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

8.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

9.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

10.  In vivo profile of the human leukocyte microRNA response to endotoxemia.

Authors:  Wolfgang M Schmidt; Alexander O Spiel; Bernd Jilma; Michael Wolzt; Markus Müller
Journal:  Biochem Biophys Res Commun       Date:  2009-01-29       Impact factor: 3.575

View more
  7 in total

1.  Inflammation, Senescence and MicroRNAs in Chronic Kidney Disease.

Authors:  Andres Carmona; Fatima Guerrero; Maria Jose Jimenez; Francisco Ariza; Marisa L Agüera; Teresa Obrero; Victoria Noci; Juan Rafael Muñoz-Castañeda; Mariano Rodríguez; Sagrario Soriano; Juan Antonio Moreno; Alejandro Martin-Malo; Pedro Aljama
Journal:  Front Cell Dev Biol       Date:  2020-08-06

2.  Whole Blood Holding Time Prior to Plasma Processing Alters microRNA Expression Profile.

Authors:  Sung Hye Kim; David A MacIntyre; Lynne Sykes; Maria Arianoglou; Phillip R Bennett; Vasso Terzidou
Journal:  Front Genet       Date:  2022-01-14       Impact factor: 4.599

3.  Tribulus terrestris L. protects glomerular endothelial cells via the miR155-H2AC6 interaction network in hypertensive renal injury.

Authors:  Hui-Juan Pei; Jie Yang; Fang-Xiao Hu; Yong-Zhi Chen; Chuan-Hua Yang
Journal:  Ann Transl Med       Date:  2021-11

4.  MicroRNAs associated with chronic kidney disease in the general population and high-risk subgroups: protocol for a systematic review and meta-analysis.

Authors:  Dipuo Dephney Motshwari; Don Makwakiwe Matshazi; Rajiv Erasmus; A P Kengne; Tandi E Matsha; Cindy George
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 2.692

5.  Key plasma microRNAs variations in patients with Plasmodium vivax malaria in Iran.

Authors:  Ramtin Hadighi; Aliehsan Heidari; Parviz Fallah; Hossein Keshavarz; Ziba Tavakoli; Mehrdokht Sadrkhanloo
Journal:  Heliyon       Date:  2022-02-27

Review 6.  Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.

Authors:  Marcella Liciani Franco; Stephany Beyerstedt; Érika Bevilaqua Rangel
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

Review 7.  Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome.

Authors:  Cristina Mas-Bargues; Matilde Alique; María Teresa Barrús-Ortiz; Consuelo Borrás; Raquel Rodrigues-Díez
Journal:  Antioxidants (Basel)       Date:  2021-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.